Poor Outcome due to the Plasmacytoid Variant of Urothelial Carcinoma

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 72-year-old man visited our hospital due to pollakiuria and lower abdominal pain. Urinary cytology was positive, and cystoscopy revealed diffuse edematous nonpapillary tumor. We performed transurethral biopsy, and clinical stage T3 plasmacytoid variant of urothelial carcinoma (PUC) was diagnosed. Although we planned for radical cystectomy, peritoneal dissemination and lung and pelvic lymph node metastases appeared 3 weeks after the initial visit. We also planned for chemotherapy; however, the metastases rapidly progressed, and he died 7 weeks after the biopsy. PUC is rare and shows an aggressive clinical course and poor prognosis.

Cite

CITATION STYLE

APA

Fukuta, K., Shiozaki, K., Kobayashi, S., Nakanishi, R., Izaki, H., Kanda, K., … Kanayama, H. O. (2022). Poor Outcome due to the Plasmacytoid Variant of Urothelial Carcinoma. Case Reports in Oncology, 15(1), 369–375. https://doi.org/10.1159/000524038

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free